Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
Holding SLXN?
Track your performance easily
SLXN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.87 - $122.01
Previous Close$2.79
Volume361.57K
Average Volume (3M)676.05K
Market Cap
$4.47M
Enterprise Value$5.21M
Total Cash (Recent Filing)$2.78M
Total Debt (Recent Filing)$144.00K
Price to Earnings (P/E)―
Beta0.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.26
Shares Outstanding14,427,814
10 Day Avg. Volume20,236,339
30 Day Avg. Volume676,053
Standard Deviation0.14
R-Squared1.00
Alpha-0.50
Financial Highlights & Ratios
Price to Book (P/B)-0.28
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda4.38
Forecast
1Y Price Target
$1.00Price Target Upside-64.16% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Silexion Therapeutics News
PremiumCompany Announcements
Biomotion Sciences’ Strategic Merger and Corporate RestructuringOwnership Overview
―
Insiders
0.33% Mutual Funds
65.34% Other Institutional Investors
34.33% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SLXN FAQ
What was Silexion Therapeutics’s price range in the past 12 months?
Silexion Therapeutics lowest stock price was $1.87 and its highest was $122.01 in the past 12 months.
What is Silexion Therapeutics’s market cap?
Currently, no data Available
When is Silexion Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Silexion Therapeutics’s earnings last quarter?
Currently, no data Available
Is Silexion Therapeutics overvalued?
According to Wall Street analysts Silexion Therapeutics’s price is currently Overvalued.
Does Silexion Therapeutics pay dividends?
Silexion Therapeutics does not currently pay dividends.
What is Silexion Therapeutics’s EPS estimate?
Silexion Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Silexion Therapeutics have?
Silexion Therapeutics has 1,603,090 shares outstanding.
What happened to Silexion Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Silexion Therapeutics?
Among the largest hedge funds holding Silexion Therapeutics’s share is Wildcat Capital Management, Llc. It holds Silexion Therapeutics’s shares valued at 5M.
---
Silexion Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.00 (-64.16% Downside)
$1.00 (-64.16% Downside)
Hedge Fund Trend
Increased
By 1.0M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.14%
12-Months-Change
Fundamentals
Return on Equity
-3.78%
Trailing 12-Months
Asset Growth
-78.29%
Trailing 12-Months
Company Description
Silexion Therapeutics
Moringa Acquisition Corp is a blank check company.
---
SLXN Stock 12 Month Forecast
Average Price Target
$1.00
▼(-64.16% Downside)
Technical Analysis
Best Analysts Covering SLXN
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+28.00%
reiterated a buy rating 26 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +28.00% per trade.
---